LVGO News and Press, Livongo Health Inc. From 11/13/20

BSTZ has been on fire, as it is invested in all the hot tech plays. The fund is paying out attractive monthly income, and shareholders just got a big boost in the amount too. BSTZ might have had an incredible run, but I don't think it is over yet. For further details see: ...

If you still had shares of Livongo, they were probably exchanged for Teladoc shares somewhere last week. We look at what's wrong with healthcare as it is now, how it can be fixed, and how Teladoc and Livongo could help to cure the system. What Livongo brings to Teladoc and what Te...

Toddler Portfolio update, Q3 2020 Results are in. Sitting tight as we ride out the election uncertainty. Front runners emerge in the watchlist for potential additions in Q4. For further details see: Toddler Portfolio: Q3 Results

Teladoc Health is unlikely to repeat the virtual visit levels of Q2/Q3 next year. The new entity has a market value of ~$30 billion after Teladoc alone was only worth a few billion to start 2019. The stock trades at a very expensive multiple of 15x combined '21 sales estimates. ...

Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO) , reported third-quarter earnings after the market close last Wednesday. While each company delivered more than 100% top-line growth, both stocks sold off on...

A 2019 paper in the journal Neuron evaluating the connection between memory and intelligence arrived at a welcome conclusion for many of us. Forgetting information isn't a malfunction of the brain. Instead, it's a healthy tool for better understanding information or getting rid of infor...

With the global robotics and automation space expected to quadruple in size over the next five years, it seems like an obvious theme for ETF investors to be over-allocated to. But with the proliferation of funds offering exposure - there are six funds with the word "Robotics" in their...

We believe shares are significantly undervalued and the market is underestimating the accretion from Livongo. Q3 results were strong, Teladoc beat EPS and revenue estimates for the quarter, and management guided FY results up - a positive revision. Long-term investors can use curr...

COVID-19 is pulling in the emergence of virtual healthcare. Teladoc posted another quarter of triple-digit growth, but the market was unimpressed. The acquisition of Livongo Health in Q4 will distance Teladoc even further from the competition and create many synergies to deliver a...

Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO) investors, in separate special shareholder meetings, overwhelmingly voted in favor of the merger of the two companies. Teladoc revealed this in a press release issued on Thursday, adding that in both cases, more t...